Research map: The TP53 p.R337H Germline Variant and Breast Cancer: Prevalence from a Cohort Study and Structured Literature Review

Back to the article

Papers in this map

  1. Hallmarks of Cancer: New Dimensions · Douglas Hanahan · 2022 · 9836 citations · Cited by this paper
  2. Clinical Significance of Apoptosis Marker Caspase-3, Tumor Marker CEA, and Electrolyte Imbalance in Breast Cancer Patients · 2026 · Related
  3. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews · Matthew James Page · 2021 · 5224 citations · Cited by this paper
  4. Barriers to Breast Cancer Screening Engagement and Early Intervention among Black African Women in the United Kingdom · 2026 · Related
  5. p53, guardian of the genome · David Philip Lane · 1992 · 5169 citations · Cited by this paper
  6. Real-World Evaluation of Trastuzumab Emtansine Biosimilar in Early-Stage HER2-Positive Breast Cancer: Results from a Single-Center Retrospective Study in India · 2026 · Related
  7. Unravelling mechanisms of p53-mediated tumour suppression · Kathryn T. Bieging · 2014 · 1421 citations · Cited by this paper
  8. Unveiling the Genomic Landscape: Architectural Insights into Triple-Negative Breast Cancer in Moroccan Patients Through Whole-Exome Sequencing · 2025 · Related
  9. The p53 Pathway: Origins, Inactivation in Cancer, and Emerging Therapeutic Approaches · Andreas C. Joerger · 2016 · 696 citations · Cited by this paper
  10. Visiting Translocons Sec Roles in Antigen Presentation in Breast Cancer · 2026 · Related
  11. The gene for human p53 cellular tumor antigen is located on chromosome 17 short arm (17p13). · O. Wesley McBride · 1986 · 368 citations · Cited by this paper
  12. Prognostic Significance of the CXCL11/CXCL9/CD163 Immune Signature in Triple-Negative Breast Cancer: A Bioinformatics and Survival Analysis · 2026 · Related
  13. Guidelines for the Li–Fraumeni and heritable TP53-related cancer syndromes · The European Reference Network GENTURIS · 2020 · 344 citations · Cited by this paper
  14. Management Challenges in Breast Angiomyxoma: Case Report and Review of the Literature · 2026 · Related
  15. A novel mechanism of tumorigenesis involving pH-dependent destabilization of a mutant p53 tetramer · Enrico L. DiGiammarino · 2001 · 293 citations · Cited by this paper
  16. Growth Inhibitory Mechanisms of Viola Yedoensis in a Model for Triple Negative Breast Cancer · 2025 · Related
  17. Are There Low-Penetrance TP53 Alleles? Evidence from Childhood Adrenocortical Tumors · Jennifer M. Varley · 1999 · 269 citations · Cited by this paper
  18. Effect of Intercostobrachial Nerve Preservation During Axillary Dissection in Breast Cancer Surgery: A Prospective Cohort Study · 2026 · Related
  19. Deconstructing networks of p53-mediated tumor suppression in vivo · Alyssa M. Kaiser · 2017 · 247 citations · Cited by this paper
  20. Holistic Understanding of Concerns of Women with Breast Cancer in Oncology Nursing: Carper‑Guided Narrative Conceptual Analysis · 2026 · Related
  21. The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families · Maria Isabel Achatz · 2006 · 216 citations · Cited by this paper
  22. Founder effect for the highly prevalent R337H mutation of tumor suppressor p53 in Brazilian patients with adrenocortical tumors · Emilia Modolo Pinto · 2004 · 153 citations · Cited by this paper
  23. Hereditary breast and ovarian cancer: assessment of point mutations and copy number variations in Brazilian patients · Felipe Cavalcanti Carneiro da Silva · 2014 · 89 citations · Cited by this paper
  24. Detection of germline variants in Brazilian breast cancer patients using multigene panel testing · Rodrigo Santa Cruz Guindalini · 2022 · 81 citations · Cited by this paper
  25. Association of the germline TP53R337H mutation with breast cancer in southern Brazil · Juliana Godoy Assumpção · 2008 · 79 citations · Cited by this paper
  26. XAF1 as a modifier of p53 function and cancer susceptibility · Emilia Modolo Pinto · 2020 · 58 citations · Cited by this paper
  27. Germline mutations in BRCA1, BRCA2, CHEK2 and TP53 in patients at high-risk for HBOC: characterizing a Northeast Brazilian Population · Gabriela ES Felix · 2014 · 53 citations · Cited by this paper
  28. Frequency of the TP53 R337H variant in sporadic breast cancer and its impact on genomic instability · Carolina Mathias · 2020 · 45 citations · Cited by this paper
  29. Potential therapeutic targets ofTP53gene in the context of its classically canonical functions and its latest non-canonical functions in human cancer · Toshimichi Tanaka · 2018 · 43 citations · Cited by this paper
  30. The R337H mutation in TP53 and breast cancer in Brazil · Magda Conceição Barbosa Gomes · 2012 · 42 citations · Cited by this paper
  31. Mutation screening of TP53, CHEK2 and BRCA genes in patients at high risk for hereditary breast and ovarian cancer (HBOC) in Brazil · Nilson Moreira Cipriano · 2018 · 42 citations · Cited by this paper
  32. A TP53 founder mutation, p.R337H, is associated with phyllodes breast tumors in Brazil · Juliana Giacomazzi · 2013 · 34 citations · Cited by this paper
  33. TP53 p.R337H prevalence in a series of Brazilian hereditary breast cancer families · Nathália Moreno Cury · 2014 · 32 citations · Cited by this paper
  34. Germline molecular data in hereditary breast cancer in Brazil: Lessons from a large single-center analysis · Renata Lazari Sandoval · 2021 · 32 citations · Cited by this paper
  35. A Fluid Salt-bridging Cluster and the Stabilization of p53 · Thu Zar Lwin · 2007 · 23 citations · Cited by this paper
  36. TP53 p.Arg337His germline mutation prevalence in Southern Brazil: Further evidence for mutation testing in young breast cancer patients · Eriza Cristina Hahn · 2018 · 17 citations · Cited by this paper
  37. Familial history and prevalence of BRCA1, BRCA2 and TP53 pathogenic variants in HBOC Brazilian patients from a public healthcare service · Bruna Palma Matta · 2022 · 15 citations · Cited by this paper
  38. The Brazilian Founder MutationTP53p.R337H is Uncommon in Portuguese Women Diagnosed with Breast Cancer · Juliana Giacomazzi · 2014 · 14 citations · Cited by this paper
  39. TP53 Pathogenic Variants in Early-Onset Breast Cancer Patients Fulfilling Hereditary Breast and Ovary Cancer and Li-Fraumeni-like Syndromes · Paula Francinete Faustino da Silva · 2022 · 5 citations · Cited by this paper

Source: OpenAlex (CC0)